Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01425008
Title Study of MLN2480 in Patients With Relapsed or Refractory Solid Tumors Followed by a Dose Expansion in Patients With Metastatic Melanoma
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Millennium Pharmaceuticals, Inc.
Indications

Advanced Solid Tumor

melanoma

Therapies

MLN2480

Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
San Francisco California United States Details
Denver Colorado United States Details
Augusta Georgia United States Details
Indianapolis Indiana United States Details
New York New York United States Details
Easton Pennsylvania United States Details
Philadelphia Pennsylvania United States Details
San Antonio Texas United States Details
Lakewood Washington United States Details
Bristol Avon United Kingdom Details
Cambridge Cambridgeshire United Kingdom Details
Chelmsford Essex United Kingdom Details
London Greater London United Kingdom Details
Manchester Greater Manchester United Kingdom Details
Oxford Oxfordshire United Kingdom Details
Newcastle upon Tyne Tyne & Wear United Kingdom Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field